Novartis will partner with PTC Therapeutics to develop PTC’s PTC518 Huntington's disease program and an unspecified number of related molecules, through an up-to-$2.9 billion exclusive global license ...

Monday’s agreement comes days after PTC discontinued the development of another asset, utreloxastat, due to disappointing ...

Gene activity in SMA may be dysregulated, but the way the disease affects genes seems to vary across types of tissues, per a ...

Researchers at Massachusetts Eye and Ear developed a preclinical research proof of concept that shows mRNA-based therapies ...

Researchers used advanced electron microscopy to capture 3D images of RNA nanoparticles during folding, revealing new ...

This study creates a comprehensive atlas of gastrointestinal cell types, revealing how stem cell-derived INFLAREs drive ...

Advanced microscopy techniques have revealed how ribosomes recruit to mRNA while it's being transcribed, potentially enabling ...

Within a cell, DNA carries the genetic code for building proteins. To build proteins, the cell makes a copy of DNA, called mRNA.

An international research collaboration has shed new light on the molecular basis of gene expression, the fundamental ...

Within a cell, DNA carries the genetic code for building proteins.To build proteins, the cell makes a copy of DNA, called mRNA. Then ...

RNA is one of the bodies most vital molecules, and it comes in a few forms. Many of them are crucial. | Cell And Molecular ...